Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis

Journal of Immunology

Volumn 176, Issue 9, 2006, Pages 5607-5615

  Kanamaru, Yutaka ^a   Scandiuzzi, Lisa ^a   Essig, Marie ^a   Brochetta, Cristiana ^a   Guérin Marchand, Claudine ^a   Tomino, Yasuhiko ^b   Monteiro, Renato C ^a   Peuchmaur, Michel ^c   Blank, Ulrich ^a  

^a INSERM   (France)

^b JUNTENDO UNIVERSITY   (Japan)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; FC RECEPTOR; FIBRIN; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR; UREA; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; FATALITY; FIBRINOLYSIS; GLOMERULONEPHRITIS; HISTOPATHOLOGY; IMMUNE COMPLEX DISEASE; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; MACROPHAGE ACTIVATION; MALE; MAST CELL; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; UREA BLOOD LEVEL;

EID: 33645971613     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.9.5607     Document Type: Article

References (74)

1. Gurish, M. F., and K. F. Austen. 2001. The diverse roles of mast cells. J. Exp. Med. 194: F1-F5.
2. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4: 787-799.
3. Galli, S. J., S. Nakae, and M. Tsai. 2005. Mast cells in the development of adaptive immune responses. Nat. Immunol. 6: 135-142.
4. Kinet, J. P. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17: 931-972.
5. Bradding, P. 2003. The role of the mast cell in asthma: a reassessment. Curr. Opin. Allergy Clin. Immunol. 3: 45-50.
6. Secor, V. H., W. E. Secor, C. A. Gutekunst, and M. A. Brown. 2000. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191: 813-822.
7. Lee, D. M., D. S. Friend, M. F. Gurish, C. Benoist, D. Mathis, and M. B. Brenner. 2002. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297: 1689-1692.
8. He, S. H. 2004. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J. Gastroenterol. 10: 309-318.
9. Abonia, J. P., D. S. Friend, W. G. Austen, Jr., F. D. Moore, Jr., M. C. Carroll, R. Chan, J. Afnan, A. Humbles, C. Gerard, P. Knight, et al. 2005. Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J. Immunol. 174: 7285-7291.
10. Coussens, L. M., and Z. Werb. 2001. Inflammatory cells and cancer: think different! J. Exp. Med. 193: F23-F26.
11. Echtenacher, B., D. N. Mannel, and L. Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77.
12. Jankovic, D., M. C. Kullberg, D. Dombrowicz, S. Barbieri, P. Caspar, T. A. Wynn, W. E. Paul, A. W. Cheever, J. P. Kinet, and A. Sher. 1997. FcεRI-deficient mice infected with Schistosoma mansoni mount normal Th2-type responses while displaying enhanced liver pathology. J. Immunol. 159: 1868-1875.
13. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381: 77-80.
14. Finkelman, F. D., and J. F. Urban, Jr. 2001. The other side of the coin: the protective role of the TH2 cytokines. J. Allergy Clin. Immunol. 107: 772-780.
15. Gurish, M. F., P. J. Bryce, H. Tao, A. B. Kisselgof, E. M. Thornton, H. R. Miller, D. S. Friend, and H. C. Oettgen. 2004. IgE enhances parasite clearance and regulates mast cell responses in mice infected with Trichinella spiralis. J. Immunol. 172: 1139-1145.
16. Blank, U., and J. Rivera. 2004. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 25: 266-273.
17. Maurer, M., T. Theoharides, R. D. Granstein, S. C. Bischoff, J. Bienenstock, B. Henz, P. Kovanen, A. M. Piliponsky, N. Kambe, H. Vliagoftis, et al. 2003. What is the physiological function of mast cells? Exp. Dermatol. 12: 886-910.
18. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852.
19. Roberts, I. S., and P. E. Brenchley. 2000. Mast cells: the forgotten cells of renal fibrosis. J. Clin. Pathol. 53: 858-862.
20. Eddy, A. A. 2001. Mast cells find their way to the kidney. Kidney Int. 60: 375-377.
21. Colvin, R. B., A. M. Dvorak, and H. F. Dvorak. 1974. Mast cells in the cortical tubular epithelium and interstitium in human renal disease. Hum. Pathol. 5: 315-326.
22. Hiromura, K., M. Kurosawa, S. Yano, and T. Naruse. 1998. Tubulointerstitial mast cell infiltration in glomerulonephritis. Am. J. Kidney Dis. 32: 593-599.
23. El Kossi, M. M., and A. M. El Nahas. 2003. Stem cell factor and crescentic glomerulonephritis. Am. J. Kidney Dis. 41: 785-795.
24. Kondo, S., S. Kagami, H. Kido, F. Strutz, G. A. Muller, and Y. Kuroda. 2001. Role of mast cell tryptase in renal interstitial fibrosis. J. Am. Soc. Nephrol. 12: 1668-1676.
25. Jones, S. E., D. J. Kelly, A. J. Cox, Y. Zhang, R. M. Cow, and R. E. Gilbert. 2003. Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int. 64: 906-913.
26. Levi-Schaffer, F., and A. M. Piliponsky. 2003. Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol. 24: 158-161.
27. Puxeddu, I., A. M. Piliponsky, I. Bachelet, and F. Levi-Schaffer. 2003. Mast cells in allergy and beyond. Int. J. Biochem. Cell Biol. 35: 1601-1607.
28. Tamaki, K., and S. Okuda. 2003. Role of TGF-β in the progression of renal fibrosis. Contrib. Nephrol. 139: 44-65.
29. Inazaki, K., Y. Kanamaru, Y. Kojima, N. Sueyoshi, K. Okumura, K. Kaneko, Y. Yamashiro, H. Ogawa, and A. Nakao. 2004. Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int. 66: 597-604.
30. Miyazawa, S., O. Hotta, N. Doi, Y. Natori, and K. Nishikawa. 2004. Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int. 65: 2228-2237.
31. Lin, L., A. J. Gerth, and S. L. Peng. 2004. Susceptibility of mast cell-deficient W/Wv mice to pristane-induced experimental lupus nephritis. Immunol. Lett. 91: 93-97.
32. Wilson, C. 1996. Renal Response to Glomerular Injury, 5th Ed. B. M. Brenner, ed. W. B. Saunders, Philadelphia, pp. 1253-1391.
33. Nocka, K., J. C. Tan, E. Chiu, T. Y. Chu, P. Ray, P. Traktman, and P. Besmer. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9: 1805-1813.
34. Kitamura, Y., S. Go, and K. Hatanaka. 1978. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52: 447-452.
35. Drew, E., J. S. Merzaban, W. Seo, H. J. Ziltener, and K. M. McNagny. 2005. CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution. Immunity 22: 43-57.
36. Kanamaru, Y., A. Nakao, M. Mamura, Y. Suzuki, I. Shirato, K. Okumura, Y. Tomino, and C. Ra. 2001. Blockade of TGF-β signaling in T cells prevents the development of experimental glomerulonephritis. J. Immunol. 166: 2818-2823.
37. Suzuki, Y., I. Shirato, K. Okumura, J. V. Ravetch, T. Takai, Y. Tomino, and C. Ra. 1998. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis. Kidney Int. 54: 1166-1174.
38. Kitching, A. R., Y. Z. Kong, X. R. Huang, P. Davenport, K. L. Edgtton, P. Carmeliet, S. R. Holdsworth, and P. G. Tipping. 2003. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J. Am. Soc. Nephrol. 14: 1487-1495.
39. Raij, L., A. P. Dalmasso, N. A. Staley, and A. J. Fish. 1989. Renal injury in DOCA-salt hypertensive C5-sufficient and C5-deficient mice. Kidney Int. 36: 582-592.
40. Essig, M., F. Vrtovsnik, G. Nguyen, J. D. Sraer, and G. Friedlander. 1998. Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. J. Am. Soc. Nephrol. 9: 1377-1388.
41. Drew, A. F., H. L. Tucker, H. Liu, D. P. Witte, J. L. Degen, and P. G. Tipping. 2001. Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am. J. Physiol. 281: F1157-F1163.
42. Sillaber, C., M. Baghestanian, D. Bevec, M. Willheim, H. Agis, S. Kapiotis, W. Fureder, H. C. Bankl, H. P. Kiener, W. Speiser, et al. 1999. The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J. Immunol. 162: 1032-1041.
43. Valent, P., M. Baghestanian, H. C. Bankl, C. Sillaber, W. R. Sperr, J. Wojta, B. R. Binder, and K. Lechner. 2002. New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cells. Thromb. Haemost. 87: 786-790.
44. Kitching, A. R., S. R. Holdsworth, V. A. Ploplis, E. F. Plow, D. Collen, P. Carmeliet, and P. G. Tipping. 1997. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J. Exp. Med. 185: 963-968.
45. Rookmaaker, M. B., A. M. Smits, H. Tolboom, K. Van't Wout, A. C. Martens, R. Goldschmeding, J. A. Joles, A. J. Van Zonneveld, H. J. Grone, T. J. Rabelink, and M. C. Verhaar. 2003. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am. J. Pathol. 163: 553-562.
46. Mondino, A., and F. Blasi. 2004. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 25: 450-455.
47. Heussen-Schemmer, C., J. R. Barron, C. R. Swanepoel, and E. B. Dowdle. 1993. Urinary tissue plasminogen activator in renal disease. Nephron 64: 42-46.
48. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15: 203-234.
49. Okayama, Y., A. S. Kirshenbaum, and D. D. Metcalfe. 2000. Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells: up-regulation by IFN-γ. J. Immunol. 164: 4332-4339.
50. Fujii, T., Y. Hamano, S. Ueda, B. Akikusa, S. Yamasaki, M. Ogawa, H. Saisho, J. S. Verbeek, S. Taki, and T. Saito. 2003. Predominant role of FcγRIII in the induction of accelerated nephrotoxic glomerulonephritis. Kidney Int. 64: 1406-1416.
51. Park, S. Y., S. Ueda, H. Ohno, Y. Hamano, M. Tanaka, T. Shiratori, T. Yamazaki, H. Arase, N. Arase, A. Karasawa, et al. 1998. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 102: 1229-1238.
52. Sheerin, N. S., T. Springall, M. C. Carroll, B. Hartley, and S. H. Sacks. 1997. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin. Exp. Immunol. 110: 403-409.
53. Tang, T., A. Rosenkranz, K. J. Assmann, M. J. Goodman, J. C. Gutierrez-Ramos, M. C. Carroll, R. S. Cotran, and T. N. Mayadas. 1997. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fc-γ receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 186: 1853-1863.
54. Clynes, R., C. Dumitru, and J. V. Ravetch. 1998. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279: 1052-1054.
55. Ehara, T., and H. Shigematsu. 2003. Mast cells in the kidney. Nephrology 8: 130-138.
56. Majeed, S. K. 1994. Mast cell distribution in mice. Arzneimittelforschung 44: 1170-1173.
57. Tanzola, M. B., M. Robbie-Ryan, C. A. Gutekunst, and M. A. Brown. 2003. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171: 4385-4391.
58. Ha, T. Y., N. D. Reed, and P. K. Crowle. 1986. Immune response potential of mast cell-deficient W/Wv mice. Int. Arch. Allergy Appl. Immunol. 80: 85-94.
59. Vasalli, P., and R. McCluskey. 1964. Pathogenic role of the coagulation process in rabbit Masugi nephritis. Am. J. Pathol. 45: 653-677.
60. Lelongt, B., S. Bengatta, M. Delauche, L. R. Lund, Z. Werb, and P. M. Ronco. 2001. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J. Exp. Med. 193: 793-802.
61. Cho, S. H., S. W. Tam, S. Demissie-Sanders, S. A. Filler, and C. K. Oh. 2000. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J. Immunol. 165: 3154-3161.
62. Wojta, J., C. Kaun, G. Zorn, M. Ghannadan, A. W. Hauswirth, W. R. Sperr, G. Fritsch, D. Printz, B. R. Binder, G. Schatzl, et al. 2002. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 100: 517-523.
63. Wershil, B. K., Y. A. Mekori, T. Murakami, and S. J. Galli. 1987. 1251-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin: demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J. Immunol. 139: 2605-2614.
64. Tchougounova, E., G. Pejler, and M. Abrink. 2003. The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue: a role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. J. Exp. Med. 198: 423-431.
65. Maier, M., J. Spragg, and L. B. Schwartz. 1983. Inactivation of human high molecular weight kininogen by human mast cell tryptase. J. Immunol. 130: 2352-2356.
66. Stack, M. S., and D. A, Johnson. 1994. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J. Biol. Chem. 269: 9416-9419.
67. Bosman, F. T., and I. Stamenkovic. 2003. Functional structure and composition of the extracellular matrix. J. Pathol. 200: 423-428.
68. Ferrao, A. V., and R. M. Mason. 1993. The effect of heparin on cell proliferation and type-I collagen synthesis by adult human dermal fibroblasts. Biochim. Biophys. Acta 1180: 225-230.
69. Holgate, S. T., M. Peters-Golden, R. A. Panettieri, and W. R. Henderson, Jr. 2003. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J. Allergy Clin. Immunol. 111: S18-34.
70. Gordon, J. R., and S. J. Galli. 1994. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the FcεRI: role for mast cell-derived transforming growth factor β and tumor necrosis factor α. J. Exp. Med. 180: 2027-2037.
71. Fajardo, I., and G. Pejler. 2003. Human mast cell β-tryptase is a gelatinase. J. Immunol. 171: 1493-1499.
72. Tchougounova, E., A. Lundequist, I. Fajardo, J. O. Winberg, M. Abrink, and G. Pejler. 2005. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280: 9291-9296.
73. Frank, B. T., J. C. Rossall, G. H. Caughey, and K. C. Fang. 2001. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by α-chymase. J. Immunol. 166: 2783-2792.
74. Baram, D., G. G. Vaday, P. Salamon, I. Drucker, R. Hershkoviz, and Y. A. Mekori. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α. J. Immunol. 167: 4008-4016.